Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm.

Clin Case Rep · 2017 · PMC5494397 · PMID 28680620

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Moreover, RAFFAELLO trial 29 demonstrated that ranolazine in doses of 500 and 750 mg reduced AF recurrences compared to placebo (borderline significance).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.